Unifying Oncologists & Pathologists
A Peer-Reviewed Journal June 2014 • Volume 3 • Number 4
PM O
BIOMARKERS • TARGETED THERAPIES • DIAGNOSTICS
Personalized Medicine in Oncology TM
IMMUNO-ONCOLOGY Immuno-Oncology Takes Center Stage at ASCO 2014...............................................Page 198
THE BIOMARKER Molecular Diversity of CLL..............................Page 202
INTERVIEW WITH THE INNOVATORS Implementing Global Healthcare: Partners In Health and the Rwandan Cancer Center Initiative. An Interview With Lawrence N. Shulman, MD, of Dana-Farber Cancer Institute.......................Page 206
PROSTATE CANCER Androgen Suppression in Castration-Resistant Prostate Cancer.................................................Page 212
VALUE-BASED CANCER CARE Personalizing Value-Based Medicine...........Page 220
THE LAST WORD PMO and the PMC – A Collaboration to Advance Precision Medicine. Introducing Dr Edward Abrahams, President of PMC, as the Author of The Last Word....................Page 238
GLOBAL BIOMARKERS CONSORTIUM Clinical Approaches to Targeted Technologies ™
The official publication of
GLOBAL BIOMARKERS CONSORTIUM Clinical Approaches to Targeted Technologies ™
WORLD CUTANEOUS MALIGNANCIES CONGRESS
© 2014 Green Hill Healthcare Communications, LLC An affiliation of The Lynx Group
WORLD CUTANEOUS
In partnership with
™